liver injury post surgery

When it comes to liver health, one might think that a Kasai portoenterostomy is a miracle solution for biliary atresia. Spoiler alert: it’s not. Sure, the immediate survival rates seem promising, with about 49.5% of patients surviving two years post-surgery. But that’s just the beginning of a rollercoaster ride.

Fast forward to ten years later, and only 52.4% still have their native liver. That’s almost like flipping a coin and hoping for the best, which, let’s be honest, isn’t the best strategy for kids’ health.

Cholangitis, anyone? A whopping 45–87% of patients experience this delightful infection after a Kasai procedure. Recurrent cholangitis doesn’t just knock at the door; it barges in and brings cirrhosis along for the ride.

And guess what? About 25% of surgeries are deemed ineffective, leading to biliary cirrhosis. So, it’s not just a “fix-it-and-forget-it” kind of deal. Two children met tragic fates due to liver issues before they even hit age 7.

Let’s not forget the other complications: portal hypertension, biliary cysts, and the infamous hepatopulmonary syndrome. It’s like a buffet of liver problems that keeps on giving.

Oh, and if you thought the timing of the surgery didn’t matter, think again. Delaying the Kasai beyond 70 days? Good luck—chances of success drop considerably.

Now, if you’re hoping for a miracle in jaundice clearance, brace yourself. Only 31.2% achieve it by the three-month mark. So much for that.

And while some patients may show stable or regressing fibrosis over time, the odds are stacked against them. With a 10-year native liver survival rate of around 50% for late surgeries, one has to wonder: is it really a miracle, or just a temporary fix?

In fact, effective bile flow restoration correlates with improved outcomes for certain patients, highlighting the complexity of post-surgical liver health.

In the world of biliary atresia, the harsh truth is that success can come with a hefty dose of long-term liver injury.

You May Also Like

Can Klebsiella Help? Harmless Strain Powerfully Protects Against Gut Infections in IBD Model

Can a harmless strain of Klebsiella turn the tide against gut infections? The surprising benefits may change everything you thought you knew.

Scientists Challenge Laxative Dogma: Why Chronic Constipation Treatments So Often Fail

Chronic constipation treatments often fail, leaving millions frustrated. What if the real solutions lie beyond laxatives? The answer might surprise you.

IBD Bowel Urgency Won’t Budge? Advanced Therapies Prove Otherwise

Tired of living in fear of bowel urgency? Advanced therapies challenge the status quo, offering hope where traditional treatments fail. Find out how.